Incannex Healthcare (IXHL) Cash & Equivalents (2020 - 2025)
Incannex Healthcare (IXHL) has disclosed Cash & Equivalents for 5 consecutive years, with $68.9 million as the latest value for Q4 2025.
- Quarterly Cash & Equivalents rose 3184.08% to $68.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $68.9 million through Dec 2025, up 3184.08% year-over-year, with the annual reading at $15.0 million for FY2025, 156.73% up from the prior year.
- Cash & Equivalents hit $68.9 million in Q4 2025 for Incannex Healthcare, down from $73.3 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $73.3 million in Q3 2025 to a low of $2.1 million in Q4 2024.
- Historically, Cash & Equivalents has averaged $20.9 million across 4 years, with a median of $9.2 million in 2021.
- Biggest five-year swings in Cash & Equivalents: plummeted 85.58% in 2024 and later surged 3184.08% in 2025.
- Year by year, Cash & Equivalents stood at $9.1 million in 2021, then surged by 59.52% to $14.6 million in 2023, then tumbled by 85.58% to $2.1 million in 2024, then soared by 3184.08% to $68.9 million in 2025.
- Business Quant data shows Cash & Equivalents for IXHL at $68.9 million in Q4 2025, $73.3 million in Q3 2025, and $15.0 million in Q2 2025.